Skip to content

Centrumapotheek Vosselaar

Active
Private limited companyfounded 2013active for 13 yearsCingel 5, 2350 Vosselaar, BelgiumKBO/BCE: BE 0538.516.977
Summary

Centrumapotheek Vosselaar has been active since 2013 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €213,808 and a net result of €186,576. Equity has been shrinking by about 8.4% per year since 2018. Its solvency ranks better than 27% of 12,775 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is 0.3% (very low).

Overview

Official details

Source: KBO
Status
Active since 04-09-2013 Normal situation
Activity
Retail sale of pharmaceutical products NACE 47730
Establishment unit
2.224.332.536 2350 Vosselaar, since 01-01-2014
Financial year end
31 December
Peppol
Reachable since 07-11-2025

Board and ownership

Board
  • Desmidt JeroenDirector · since 01-09-2013

Financial position

84 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
0.3%
Annual accounts 2025
Gross margin
€614,795
▲ 10.1%
Turnover
≈ €2.2m
estimated
Profit
€186,576
▲ 16.2%
Equity
€213,808
▼ 22.4%
Total assets
€1.3m
▲ 17.9%
Employees on 31-12-2025
5
▼ 16.7%
Score breakdownraises riskEquity €213,808 (16.0% of total assets)Sector: Retail trade (NACE 47)lowers riskSize: 3.6 FTE, total assets €1.3mFigures for financial year 2025 (filed on 23-06-2026)Show the evidence

Checked score

Score 2025
84 / 100
Excellent
Probability in this band: under 0.55%
Financially stronger than 41% of micro companies in retail trade (NACE 47)
Financial strength · tick: 2024
Average
Solvency 41-8
equity 16.0% of total assets
Liquidity 35-5
short-term debt 60.5% · cash 12.9%
Profitability 86=
return on assets 13.9%
Bankruptcy probability within 12 months
0.3% Very low
0%0.5%1.5%4%10%≥ 25%

About 3 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.6% (40,272 companies, NACE 47, micro)
Last 24 months 12-2024: 0.2% 01-2025: 0.2%● unchanged vs 12-2024 02-2025: 0.2%● unchanged vs 01-2025 03-2025: 0.2%● unchanged vs 02-2025 04-2025: 0.2%● unchanged vs 03-2025 05-2025: 0.2%● unchanged vs 04-2025 06-2025: 0.3%▲ +0.1 percentage points vs 05-2025 07-2025: 0.5%▲ +0.2 percentage points vs 06-2025highest value 08-2025: 0.2%▼ -0.3 percentage points vs 07-2025lowest value 09-2025: 0.2%● unchanged vs 08-2025lowest value 10-2025: 0.2%● unchanged vs 09-2025lowest value 11-2025: 0.2%● unchanged vs 10-2025lowest value 12-2025: 0.2%● unchanged vs 11-2025lowest value 01-2026: 0.2%● unchanged vs 12-2025lowest value 02-2026: 0.2%● unchanged vs 01-2026 03-2026: 0.2%● unchanged vs 02-2026 04-2026: 0.2%● unchanged vs 03-2026 05-2026: 0.2%● unchanged vs 04-2026 06-2026: 0.3%▲ +0.1 percentage points vs 05-2026 07-2026: 0.3%● unchanged vs 06-2026 08-2026: 0.3%● unchanged vs 07-2026 09-2026: 0.3%● unchanged vs 08-2026 10-2026: 0.3%● unchanged vs 09-2026 11-2026: 0.3%● unchanged vs 10-2026
Credit of up to €17,000 on 30-day terms is acceptable
Liquidity is tight, with a current ratio of 1.18 (1.47 in 2024), below the usual 1.5. Short-term debt is 60.5% and cash 12.9% of total assets. 84% of the assets are financed with debt and provisions.
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 47, micro). It does better than 32% of them on solvency, 32% on liquidity, 81% on profitability and 19% on growth.

The bankruptcy probability was computed on 01-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Five signals.
lowers riskraises riskneutral
raises risk · Equity €213,808 (16.0% of total assets)
NBB · annual accounts
lowers risk · Size: 3.6 FTE, total assets €1.3m
Companies of this size fail less often. How much that weighs depends on the rest of the company's profile.
NBB · annual accounts
lowers risk · Figures for financial year 2025 (filed on 23-06-2026)
NBB · annual accounts
raises risk · Sector: Retail trade (NACE 47)
KBO
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 23-06-2026, 38 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
38 days early
2024
16 days early
2023
33 days early
2022
33 days early
2021
25 days early
2020
11 days early
2019
2 days early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

The company filed its last 7 accounts on average 23 days before the deadline. In the sector (NACE 47), the median for financial year 2024 was on the deadline day, and 47% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 29 June (5 of the last 5 accounts filed within 30 days either side of that date).
Companies Code · seven months
Where today falls in the filing period
02-11-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
That holds for every publication since 2021.
KBO publications

Key points

  • Positive: Higher net result than 87% of companies in retail tradesector median €27,601 · 12,764 companies €186,576 View
  • Positive: 8 profitable years in a rowprofit 2025: €186,576 8 years View
  • Positive: Filed on time since financial year 2019accounts within the deadline every year 7 years View

Recent changes

  1. · Gazette deed Amendment of the articles · Legal-form change · Resignations & appointments
  2. · Gazette deed Incorporation
All 13 events

Comparable companies

These companies have the same main activity as Centrumapotheek Vosselaar: retail sale of pharmaceutical products (NACE 47730). They are comparable in size and age: total assets between €1.1m and €1.4m, founded between 2009 and 2015.

CompanyTotal assetsGross margin
Centrumapotheek Vosselaar Vosselaar€1.3m€0.6m
APOTHEEK FARMAPUNT MORTSEL Mortsel€1.2m€0.6m
GLOBAL-E-CARE Antwerpen€1.4m€0.6m
PHARMA WERBOMONT Ferrières€1.3m€0.5m
Pharmacie Scutnaire La Louvière€1.1m€0.5m
Pharmacie Smits Basse Wavre Wavre€1.2m€0.5m
Pharmacie Van Gelder Colfontaine€1.1m€0.5m
Full comparison

Key facts about Centrumapotheek Vosselaar

What is the company number of Centrumapotheek Vosselaar?
The company number of Centrumapotheek Vosselaar is 0538.516.977. The VAT number is the same number with BE in front: BE 0538.516.977.
Where is Centrumapotheek Vosselaar based?
The registered office is at Cingel 5, 2350 Vosselaar.Company details
What does Centrumapotheek Vosselaar do?
According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
What is the legal form of Centrumapotheek Vosselaar?
The legal form of Centrumapotheek Vosselaar is Private limited company (BV).
When was Centrumapotheek Vosselaar founded?
Centrumapotheek Vosselaar was founded on 04-09-2013.
Is Centrumapotheek Vosselaar still active?
Yes, Centrumapotheek Vosselaar is an active enterprise in the KBO register.
How many employees does Centrumapotheek Vosselaar have?
Centrumapotheek Vosselaar had an average of 3.6 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
What is the turnover of Centrumapotheek Vosselaar?
The turnover in financial year 2025 is ≈ €2.2m. This figure is estimated from the gross margin of €614,795 and 47 comparable companies (NACE 477). It probably lies between €1.7m and €3.7m.
Is Centrumapotheek Vosselaar profitable?
In financial year 2025, Centrumapotheek Vosselaar made a profit of €186,576.
Where can I find the annual accounts of Centrumapotheek Vosselaar?
Centrumapotheek Vosselaar filed 12 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of Centrumapotheek Vosselaar due?
Centrumapotheek Vosselaar must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.